Annual report pursuant to Section 13 and 15(d)

Note 8 - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.23.1
Note 8 - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Net operating loss carryforwards $ 54,845 $ 49,280
Share-based awards compensation, tax assets 3,112 2,739
Accrued expenses, tax assets 216 323
R&D Credits 413 0
Depreciation and other 384 384
Unrealized foreign currency 359 256
Capitalized R&D 952 0
Lease liability 3,541 4,022
Total deferred tax assets 63,822 57,004
Right-of-use asset (3,270) (3,729)
Accrued expenses 0 (68)
Total deferred tax liabilities (3,270) (3,797)
Less: valuation allowance: (60,552) (53,207)
Net deferred tax asset $ 0 $ 0